Tectonic Therapeutic Inc Statistics
Share Statistics
Tectonic Therapeutic Inc has 14.75M shares outstanding. The number of shares has increased by null% in one year.
| Shares Outstanding | 14.75M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Institutions (%) | n/a |
| Shares Floating | - |
| Failed to Deliver (FTD) Shares | 949 |
| FTD / Avg. Volume | 0.71% |
Short Selling Information
The latest short interest is 331.76K, so 2.25% of the outstanding shares have been sold short.
| Short Interest | 331.76K |
| Short % of Shares Out | 2.25% |
| Short % of Float | 4.26% |
| Short Ratio (days to cover) | 3.17 |
Valuation Ratios
The PE ratio is -1.41 and the forward PE ratio is -10.28.
| PE Ratio | -1.41 |
| Forward PE | -10.28 |
| PS Ratio | 0 |
| Forward PS | null |
| PB Ratio | 0.64 |
| P/FCF Ratio | -1.47 |
| PEG Ratio | n/a |
Enterprise Valuation
Tectonic Therapeutic Inc has an Enterprise Value (EV) of -.
| EV / Earnings | null |
| EV / Sales | null |
| EV / EBITDA | null |
| EV / EBIT | null |
| EV / FCF | null |
Financial Position
The company has a current ratio of 4.86, with a Debt / Equity ratio of 0.
| Current Ratio | 4.86 |
| Quick Ratio | 4.86 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0 |
| Cash Flow / Debt | 0 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -0.45% and return on capital (ROIC) is -45.46%.
| Return on Equity (ROE) | -0.45% |
| Return on Assets (ROA) | -0.42% |
| Return on Capital (ROIC) | -45.46% |
| Revenue Per Employee | 0 |
| Profits Per Employee | -973.25K |
| Employee Count | 44 |
| Asset Turnover | 0 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 377.00K |
| Effective Tax Rate | -0.01 |
Stock Price Statistics
The stock price has increased by 178.31% in the last 52 weeks. The beta is 0, so Tectonic Therapeutic Inc's price volatility has been lower than the market average.
| Beta | 0 |
| 52-Week Price Change | 178.31% |
| 50-Day Moving Average | 42.06 |
| 200-Day Moving Average | 23.39 |
| Relative Strength Index (RSI) | 47.47 |
| Average Volume (20 Days) | 134.46K |
Income Statement
In the last 12 months, Tectonic Therapeutic Inc had revenue of $0 and earned -$42.82M in profits. Earnings per share was $-11.59.
| Revenue | 0 |
| Gross Profit | -617.00K |
| Operating Income | -44.65M |
| Net Income | -42.82M |
| EBITDA | -43.17M |
| EBIT | - |
| Earnings Per Share (EPS) | -11.59 |
Balance Sheet
The company has $28.77M in cash and $4.34M in debt, giving a net cash position of $24.43M.
| Cash & Cash Equivalents | 28.77M |
| Total Debt | 4.34M |
| Net Cash | 24.43M |
| Retained Earnings | -477.27M |
| Total Assets | 168.72M |
| Working Capital | 145.28M |
Cash Flow
In the last 12 months, operating cash flow was -$40.68M and capital expenditures -$8.00K, giving a free cash flow of -$40.96M.
| Operating Cash Flow | -40.68M |
| Capital Expenditures | -8.00K |
| Free Cash Flow | -40.96M |
| FCF Per Share | -11.09 |
Margins
Gross margin is 0%, with operating and profit margins of 0% and 0%.
| Gross Margin | 0% |
| Operating Margin | 0% |
| Pretax Margin | 0% |
| Profit Margin | 0% |
| EBITDA Margin | n/a% |
| EBIT Margin | n/a% |
| FCF Margin | n/a% |
Dividends & Yields
TECX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -25.52% |
| FCF Yield | -6.11% |
Analyst Forecast
The average price target for TECX is $72.5, which is 59.6% higher than the current price. The consensus rating is "Buy".
| Price Target | $72.5 |
| Price Target Difference | 59.6% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
Stock Splits
The last stock split was on Jun 21, 2024. It was a backward split with a ratio of 1:12.
| Last Split Date | Jun 21, 2024 |
| Split Type | backward |
| Split Ratio | 1:12 |
Scores
| Altman Z-Score | 21.34 |
| Piotroski F-Score | 1 |